Clinical and Care Delivery News

Effective testing, treatment and vaccines represent three key components of the health care industry’s response to COVID-19. As the pandemic surges across much of the country, new rapid testing and treatment innovations could help turn the tables on the virus.

As COVID-19 unfolded across the nation, the risk for health systems with an entirely fee-for-service reimbursement system was exposed. Now nine months into the pandemic, it is increasingly clear that COVID-19 may just be the disruptive force that causes those health systems to move decisively toward a reimbursement structure more aligned with value. Here are five value-based care strategies that should be top of mind going into 2021.

COVID-19 vaccines are advancing through development with unprecedented speed and several are in the final stages of clinical trials. To help members keep up with clinical development efforts, Vizient launched a COVID-19 vaccine resource center, offering insights, tools, and the latest information on the development of COVID-19 vaccines.

The perceptions of patients regarding the safety of elective procedures has steadily improved since May, as shown in Vizient’s updated report Connecting With Patients During COVID-19. However, this has not translated into increased utilization of health care services.